Chemical Synthesis Method of Plesiomonas Shigelloides Serotype O51 O-antigen Oligosaccharide
US-2019233459-A1 · Aug 1, 2019 · US
Oral vaccination of fish with live attenuated Edwardsiella ictaluri vaccines
US8999319B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8999319-B2 |
| Application number | US-201113261536-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 9, 2011 |
| Priority date | Jun 9, 2010 |
| Publication date | Apr 7, 2015 |
| Grant date | Apr 7, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention is directed to a novel live attenuated isolate and sub-isolets thereof of a strain of the pathogen Edwardsiella ictaluri for protecting fish from ESC infection or disease, a vaccine composition comprising the isolet, a method of oral delivery of the vaccine and any vaccine, and an apparatus designed to effectively mix the vaccine with fish feed and deliver the vaccine to fish.
First claim
Opening claim text (preview).
What is claimed is: 1. A live attenuated cultured isolate of a strain of the gram negative enteric bacterium pathogen Edwardsiella ictaluri that is resistant to rifamycin and that protects fish from virulent isolate E. ictaluri strains and infection, wherein the live attenuated cultured isolate of a strain of E. ictaluri is selected from at least one or more of the sub-isolates of the attenuated culture S97-773-340X. 2. The isolate of claim 1 , wherein th…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
- A61K39/025Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8999319B2 cover?
- The present invention is directed to a novel live attenuated isolate and sub-isolets thereof of a strain of the pathogen Edwardsiella ictaluri for protecting fish from ESC infection or disease, a vaccine composition comprising the isolet, a method of oral delivery of the vaccine and any vaccine, and an apparatus designed to effectively mix the vaccine with fish feed and deliver the vaccine to…
- Who is the assignee on this patent?
- Wise David J, Greenway Terrence, Byars Todd, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K39/025. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).